This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: James Zanghi: Innovator in Antibody Treatment Methods
Introduction
James Zanghi is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of medical treatments, particularly through his innovative work with antibodies. His research focuses on methods that target the colony stimulating factor 1 receptor (CSF1R), which plays a crucial role in various medical conditions.
Latest Patents
James Zanghi holds a patent for "Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)." This patent outlines methods that include, but are not limited to, treating rheumatoid arthritis. His work in this area demonstrates a commitment to advancing therapeutic options for patients suffering from autoimmune diseases.
Career Highlights
Zanghi is currently employed at Five Prime Therapeutics, Inc., where he continues to develop innovative treatments. His role at the company allows him to collaborate with other talented professionals in the field. His contributions have been instrumental in pushing the boundaries of antibody-based therapies.
Collaborations
James Zanghi has worked alongside colleagues such as Emma Masteller and Julie Hambleton. These collaborations have fostered a productive environment for research and development, leading to advancements in their shared field of expertise.
Conclusion
James Zanghi's work in antibody treatment methods exemplifies the impact of innovation in medical science. His patent and ongoing research contribute to the development of effective therapies for conditions like rheumatoid arthritis. His dedication to improving patient outcomes through scientific discovery is commendable.